NYSE:CI - Cigna Stock Price, Price Target & More

$169.94 -1.79 (-1.04 %)

(As of 04/20/2018 04:00 PM ET)

Previous Close$169.94

Today's Range$169.6301 - $172.55

52-Week Range$152.89 - $227.13

Volume2.99 million shs

Average Volume2.25 million shs

Market Capitalization$41.71 billion

P/E Ratio16.25

Dividend Yield0.02%

Beta0.6

About Cigna (NYSE:CI)

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Receive CI News and Ratings via Email

Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans

Sub-IndustryManaged Health Care

SectorFinance

SymbolNYSE:CI

CUSIP12550910

Webwww.cigna.com

Phone860-226-6000

Debt

Debt-to-Equity Ratio0.38%

Current Ratio0.37%

Quick Ratio0.37%

Price-To-Earnings

Trailing P/E Ratio16.25

Forward P/E Ratio13.18

P/E Growth1.03

Sales & Book Value

Annual Sales$41.62 billion

Price / Sales0.99

Cash Flow$12.9824 per share

Price / Cash13.09

Book Value$55.71 per share

Price / Book3.05

Profitability

EPS (Most Recent Fiscal Year)$10.46

Net Income$2.24 billion

Net Margins5.38%

Return on Equity18.84%

Return on Assets4.33%

Miscellaneous

Employees46,000

Outstanding Shares242,880,000

How to Become a New Pot Stock Millionaire

Cigna (NYSE:CI) Frequently Asked Questions

What is Cigna's stock symbol?

Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

How often does Cigna pay dividends? What is the dividend yield for Cigna?

Cigna announced a quarterly dividend on Wednesday, February 28th. Stockholders of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.09%. The ex-dividend date of this dividend is Friday, March 9th. View Cigna's Dividend History.

How will Cigna's stock buyback program work?

Cigna declared that its board has initiated a stock buyback program on Sunday, June 4th 2017, which authorizes the company to buyback $3,700,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 9.8% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its stock is undervalued.

How were Cigna's earnings last quarter?

Cigna (NYSE:CI) released its quarterly earnings data on Thursday, February, 1st. The health services provider reported $1.94 EPS for the quarter, beating the Zacks' consensus estimate of $1.87 by $0.07. The health services provider earned $10.53 billion during the quarter, compared to the consensus estimate of $10.28 billion. Cigna had a net margin of 5.38% and a return on equity of 18.84%. The firm's quarterly revenue was up 5.9% compared to the same quarter last year. During the same period last year, the firm posted $1.87 EPS. View Cigna's Earnings History.

When is Cigna's next earnings date?

Cigna is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Cigna.

What guidance has Cigna issued on next quarter's earnings?

Cigna updated its FY18 earnings guidance on Thursday, February, 1st. The company provided EPS guidance of $12.40-12.90 for the period, compared to the Thomson Reuters consensus estimate of $12.18. The company issued revenue guidance of +7-8% to ~$44.53-44.95 billion, compared to the consensus revenue estimate of $43.87 billion.

What price target have analysts set for CI?

18 analysts have issued 12-month price objectives for Cigna's stock. Their forecasts range from $174.00 to $255.00. On average, they anticipate Cigna's share price to reach $209.2222 in the next year. View Analyst Ratings for Cigna.

What are Wall Street analysts saying about Cigna stock?

Here are some recent quotes from research analysts about Cigna stock:

1. According to Zacks Investment Research, "Cigna’s shares have underperformed the industry in a year. The company has been witnessing increase in leverage. Suspension of share buyback and huge execution risk related to the recent deal are some of the major concerns. Its Medicare business is also expected to remain under pressure. The company has also received negative rating action from the rating agencies. However, the company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and equip it better to face stiff competition. Synergies from the acquisition should buoy the company's long-term growth potential. Its robust Global Supplemental business, growing Government business and increasing membership, and strong capital position are the other positives. A strong outlook for 2018 reflects its business strength. Moreover, it has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the last 30 days." (4/16/2018)
2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)

Who are some of Cigna's key competitors?

Some companies that are related to Cigna include Australia and New Zealand Banking Group (ANZ), National Australia Bank (NAB), China Life Insurance (LFC), Industrial & Cmrcl Bnk f China (IDCBY), Banco Bradesco (BBD), Westpac (WBK), Charles Schwab (SCHW), Scotiabank (BNS), AXA (AXAHY), Lloyds Banking Group (LYG), PNC Financial Services Group (PNC), UBS (UBS), ING Groep (ING), Prudential (PUK), Bank of Montreal (BMO), Chubb (CB), Altaba (AABA) and Powershares QQQ Trust Series 1 (QQQ).

Who are Cigna's key executives?

Cigna's management team includes the folowing people:

Mr. David Michael Cordani, CEO, Pres & Director (Age 53)
Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
Mr. Jason D. Sadler, Pres of International Markets (Age 49)
Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer

Has Cigna been receiving favorable news coverage?

Media stories about CI stock have trended somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cigna earned a news sentiment score of 0.12 on Accern's scale. They also gave news coverage about the health services provider an impact score of 48.08 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Cigna?

Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cigna's stock price today?

One share of CI stock can currently be purchased for approximately $169.94.

How big of a company is Cigna?

Cigna has a market capitalization of $41.71 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. Cigna employs 46,000 workers across the globe.

How can I contact Cigna?

Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]

MarketBeat Community Rating for Cigna (CI)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		587 (Vote Outperform)
Underperform Votes:		389 (Vote Underperform)
Total Votes:		976

MarketBeat's community ratings are surveys of what our community members think about Cigna and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Cigna (NYSE:CI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

18 Wall Street analysts have issued ratings and price targets for Cigna in the last 12 months. Their average twelve-month price target is $209.2222, suggesting that the stock has a possible upside of 23.12%. The high price target for CI is $255.00 and the low price target for CI is $174.00. There are currently 4 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.78	2.78	2.81	2.87
Ratings Breakdown:	0 Sell Rating(s) 4 Hold Rating(s) 14 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 4 Hold Rating(s) 14 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 3 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 13 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$209.2222	$209.2222	$203.5625	$192.0667
Price Target Upside:	23.12% upside	25.05% upside	0.49% upside	3.83% upside

Cigna (NYSE:CI) Consensus Price Target History

Price Target History for Cigna (NYSE:CI)

Cigna (NYSE:CI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/13/2018	Sanford C. Bernstein	Initiated Coverage	Mkt Perform -> Market Perform	$194.00	Medium
3/12/2018	Credit Suisse Group	Lower Price Target	Outperform -> Outperform	$232.00 -> $215.00	High
3/8/2018	Barclays	Initiated Coverage	Overweight -> Overweight	$235.00	High
2/2/2018	Oppenheimer	Boost Price Target	Outperform	$237.00	Medium
2/2/2018	Morgan Stanley	Boost Price Target	Overweight -> Overweight	$255.00	Low
1/3/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$247.00	Medium
11/3/2017	Citigroup	Boost Price Target	Buy	$198.00 -> $231.00	N/A
11/3/2017	Jefferies Group	Boost Price Target	Buy	$221.00 -> $231.00	N/A
11/3/2017	Royal Bank of Canada	Reiterated Rating	Outperform -> Outperform	$185.00 -> $220.00	N/A
10/16/2017	BMO Capital Markets	Initiated Coverage	Market Perform	$210.00	N/A
9/17/2017	Piper Jaffray	Reiterated Rating	Buy	$191.00	Low
8/7/2017	Deutsche Bank	Boost Price Target	Buy	$180.00 -> $190.00	Low
6/23/2017	Bank of America	Boost Price Target	Buy	$193.00 -> $198.00	Medium
6/22/2017	UBS	Reiterated Rating	Buy	$186.00 -> $193.00	N/A
6/19/2017	Wells Fargo	Reiterated Rating	Market Perform	$163.00 -> $174.00	Low
6/15/2017	CIBC	Boost Price Target	Outperform	$174.00 -> $185.00	Medium
6/1/2017	Cowen	Reiterated Rating	Outperform	$160.00 -> $185.00	Low
5/15/2017	Stifel Nicolaus	Boost Price Target	Buy	$170.00 -> $175.00	N/A
9/26/2016	Leerink Swann	Reiterated Rating	Buy	$155.00	N/A
9/22/2016	Evercore ISI	Initiated Coverage	Hold	$134.00	N/A
8/31/2016	William Blair	Reiterated Rating	Buy		N/A
6/28/2016	Wolfe Research	Initiated Coverage	Outperform	$172.00	N/A
6/20/2016	FBR & Co	Reiterated Rating	Hold		N/A

(Data available from 4/21/2016 forward)

Cigna (NYSE:CI) Earnings History and Estimates Chart

Cigna (NYSE:CI) Earnings Estimates

2018 EPS Consensus Estimate: $12.38
2019 EPS Consensus Estimate: $12.60

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$2.81	$3.51	$3.26
Q2 2018	3	$2.87	$3.60	$3.34
Q3 2018	3	$2.86	$3.47	$3.27
Q4 2018	3	$2.47	$2.60	$2.52
Q1 2019	1	$3.27	$3.27	$3.27
Q2 2019	1	$3.30	$3.30	$3.30
Q3 2019	1	$3.21	$3.21	$3.21
Q4 2019	1	$2.82	$2.82	$2.82

Cigna (NYSE CI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018		$3.27					N/A
2/1/2018	Q4 2017	$1.87	$1.94	$10.2831 billion	$10.5310 billion	View	N/A
11/2/2017	Q3 2017	$2.36	$2.83	$10.1728 billion	$10.3820 billion	View	N/A
8/4/2017	Q2 2017	$2.48	$2.91	$10.2580 billion	$10.3180 billion	View	N/A
5/5/2017	Q1 2017	$2.44	$2.77	$10.1083 billion	$10.3850 billion	View	N/A
2/2/2017	Q416	$1.74	$1.87	$9.88 billion	$9.94 billion	View	Listen
11/3/2016	Q316	$1.91	$1.94	$4.37 billion	$9.90 billion	View	N/A
7/29/2016	Q216	$2.39	$1.98	$9.98 billion	$9.89 billion	View	Listen
5/6/2016	Q116	$2.16	$2.32	$9.98 billion	$9.90 billion	View	N/A
2/4/2016	Q415	$1.80	$1.87	$9.52 billion	$9.53 billion	View	N/A
11/6/2015	Q315	$2.18	$2.28	$9.51 billion	$9.3890 billion	View	N/A
7/30/2015	Q215	$2.38	$2.55	$9.53 billion	$9.50 billion	View	N/A
4/30/2015	Q115	$1.85	$1.96	$9.28 billion	$9.50 billion	View	N/A
2/5/2015	Q414	$1.65	$1.69	$8.89 billion	$8.93 billion	View	N/A
10/30/2014	Q314	$1.81	$1.95	$8.64 billion	$8.80 billion	View	N/A
7/31/2014	Q214	$1.85	$1.96	$7.61 billion	$8.73 billion	View	N/A
5/1/2014	Q114	$1.54	$1.83	$7.72 billion	$8.50 billion	View	Listen
2/7/2014	Q413	$1.63	$1.39	$7.30 billion	$8.1510 billion	View	Listen
10/31/2013	Q313	$1.62	$1.89	$7.24 billion	$8.07 billion	View	Listen
8/1/2013	Q2 2013	$1.60	$1.78	$7.38 billion	$7.98 billion	View	N/A
5/2/2013	Q1 2013	$1.42	$1.72	$7.25 billion	$8.18 billion	View	Listen
2/7/2013	Q4 2012	$1.48	$1.41	$6.72 billion	$7.62 billion	View	Listen
11/1/2012	Q312	$1.36	$1.71	$6.63 billion	$7.36 billion	View	N/A
8/2/2012		$1.41	$1.52			View	N/A
5/3/2012		$1.30	$1.28			View	N/A
2/2/2012		$1.18	$1.11			View	N/A
10/28/2011		$1.22	$1.20			View	N/A
8/4/2011		$1.29	$1.53			View	N/A
5/5/2011		$1.09	$1.37			View	N/A
2/3/2011		$1.02	$1.15			View	N/A
10/29/2010	Q3 2010	$1.06	$1.10			View	N/A
8/5/2010	Q2 2010	$1.01	$1.38			View	N/A
5/6/2010	Q1 2010	$0.89	$1.01			View	N/A
2/4/2010	Q4 2009	$0.96	$1.03			View	N/A
11/5/2009	Q3 2009	$1.03	$1.13			View	N/A
7/30/2009	Q2 2009	$0.96	$1.14			View	N/A
4/30/2009	Q1 2009	$0.90	$0.69			View	N/A
2/5/2009	Q4 2008	$0.43	$0.49			View	N/A
10/30/2008	Q3 2008	$1.06	$0.89			View	N/A
8/1/2008	Q2 2008	$0.98	$1.08			View	N/A
5/1/2008	Q1 2008	$0.96	$0.94			View	N/A
2/6/2008	Q4 2007	$0.98	$0.98			View	N/A

(Earnings results data provided by Zacks Investment Research)

Cigna (NYSE:CI) Dividend Information

Cigna pays an annual dividend of $0.04 per share, with a dividend yield of 0.02%. CI's most recent quarterly dividend payment was Tuesday, April 10. Cigna pays out 0.38% of its earnings out as a dividend.

Most Recent Dividend:	4/10/2018
Annual Dividend:	$0.04
Dividend Yield:	0.02%
Dividend Growth:	0.00% (3 Year Average)
Payout Ratio:	0.38% (Trailing 12 Months of Earnings) 0.31% (Based on This Year's Estimates) 0.28% (Based on Next Year's Estimates)

Dividend Payments by Quarter for Cigna (NYSE:CI)

Cigna (NYSE:CI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/28/2018	quarterly	$0.04	0.1%	3/9/2018	3/12/2018	4/10/2018
2/22/2017	quarterly	$0.04	0.03%	3/8/2017	3/10/2017	4/10/2017
2/25/2016	annual	$0.04	0.03%	3/9/2016	3/11/2016	4/11/2016
2/26/2015	annual	$0.04	0.03%	3/10/2015	3/12/2015	4/10/2015
2/26/2014	quarterly	$0.04	0.05%	3/10/2014	3/12/2014	4/9/2014
3/1/2013	annual	$0.04	0.07%	3/8/2013	3/12/2013	4/10/2013
2/28/2013	quarterly	$0.04			3/12/2013	4/10/2013

(Data available from 1/1/2013 forward)

Cigna (NYSE CI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.10%
Institutional Ownership Percentage: 88.80%

Insider Trading History for Cigna (NYSE:CI)

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Cigna (NYSE CI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2018	Christopher J Hocevar	Insider	Sell	2,759	$191.84	$529,286.56	12,784
3/5/2018	David Cordani	CEO	Sell	36,769	$191.68	$7,047,881.92	372,076
3/5/2018	Nicole S Jones	EVP	Sell	5,856	$190.68	$1,116,622.08	36,658
1/18/2018	John M Murabito	EVP	Sell	6,099	$220.10	$1,342,389.90	68,026
1/16/2018	Donna F. Zarcone	Director	Sell	5,971	$215.43	$1,286,332.53
1/12/2018	Jane E. Md Henney	Director	Sell	400	$212.96	$85,184.00
1/10/2018	John M Murabito	EVP	Sell	28,037	$205.68	$5,766,650.16	60,290
1/10/2018	William D Zollars	Director	Sell	212	$205.68	$43,604.16	13,500
12/11/2017	Isaiah Harris, Jr.	Chairman	Sell	212	$209.35	$44,382.20
11/27/2017	Alan Muney	EVP	Sell	15,345	$200.80	$3,081,276.00	28,457
11/27/2017	Christopher J Hocevar	Insider	Sell	8,387	$200.32	$1,680,083.84	12,363
11/13/2017	Michael W Triplett	Insider	Sell	10,417	$197.77	$2,060,170.09	32,347
11/9/2017	Mary T Hoeltzel	CAO	Sell	575	$197.03	$113,292.25	2,499
9/13/2017	William D. Zollars	Director	Sell	1,232	$187.23	$230,667.36
9/12/2017	Isaiah Harris, Jr.	Chairman	Sell	247	$185.27	$45,761.69
8/16/2017	Lisa R Bacus	EVP	Sell	2,236	$179.95	$402,368.20	18,501
8/9/2017	Mary T Hoeltzel	VP	Sell	525	$177.59	$93,234.75	1,924
8/8/2017	Michael W Triplett	Insider	Sell	3,700	$174.96	$647,352.00	21,060
8/7/2017	Jason D Sadler	Insider	Sell	37,756	$176.16	$6,651,096.96	47,844
7/24/2017	Jane E. Md Henney	Director	Sell	600	$174.14	$104,484.00
7/21/2017	Matthew G Manders	Insider	Sell	24,357	$175.01	$4,262,718.57	46,256
6/19/2017	David Cordani	CEO	Sell	153,168	$170.20	$26,069,193.60	421,162
6/14/2017	Michael W Triplett	Insider	Sell	1,439	$166.89	$240,154.71	26,199
6/6/2017	Mary T Hoeltzel	VP	Sell	500	$166.70	$83,350.00	2,449
6/5/2017	Jason D Sadler	Insider	Sell	1,727	$164.59	$284,246.93	34,504
6/2/2017	Matthew G Manders	Insider	Sell	6,000	$165.00	$990,000.00	33,799
5/24/2017	Lisa R Bacus	EVP	Sell	11,455	$161.57	$1,850,784.35	24,753
5/17/2017	Nicole S Jones	EVP	Sell	20,312	$160.04	$3,250,732.48	44,737
4/24/2017	Jane E. Md Henney	Director	Sell	600	$156.92	$94,152.00
4/10/2017	Jason D Sadler	Insider	Sell	4,213	$152.01	$640,418.13	36,231
2/27/2017	David Cordani	CEO	Sell	43,637	$147.78	$6,448,675.86	306,194
2/27/2017	Matthew G Manders	Insider	Sell	8,309	$146.54	$1,217,600.86	39,799
2/27/2017	Thomas A Mccarthy	CFO	Sell	4,464	$146.54	$654,154.56	80,531
12/20/2016	Jason D Sadler	Insider	Sell	2,000	$138.10	$276,200.00	32,019
11/7/2016	John M Murabito	EVP	Sell	58,822	$125.09	$7,358,043.98	115,109
10/31/2016	Jason D Sadler	Insider	Sell	4,000	$121.80	$487,200.00	34,019
8/17/2016	Mary T Hoeltzel	VP	Sell	500	$132.28	$66,140.00	4,017
12/8/2015	Isaiah Harris Jr	Chairman	Sell	333	$137.00	$45,621.00	13,500
11/16/2015	Herbert A. Fritch	insider	Sell	40,157	$133.18	$5,348,109.26	274,545
10/15/2015	Herbert A. Fritch	insider	Sell	39,202	$136.66	$5,357,345.32	279,313
9/15/2015	Herbert A. Fritch	insider	Sell	39,174	$139.66	$5,471,040.84	283,125
8/17/2015	Herbert A Fritch	Insider	Sell	38,489	$144.36	$5,556,272.04
7/15/2015	Herbert A Fritch	Insider	Sell	37,918	$155.96	$5,913,691.28
6/15/2015	Herbert A Fritch	Insider	Sell	38,045	$145.15	$5,522,231.75
6/8/2015	Isaiah Harris Jr	Chairman	Sell	319	$139.48	$44,494.12
4/15/2015	Herbert A Fritch	Insider	Sell	38,080	$132.99	$5,064,259.20
3/16/2015	Herbert A Fritch	Insider	Sell	38,377	$124.40	$4,774,098.80
3/9/2015	Isaiah Harris Jr	Chairman	Sell	369	$120.64	$44,516.16
3/2/2015	Nicole S Jones	EVP	Sell	8,659	$121.88	$1,055,358.92
2/10/2015	Mary T Hoeltzel	CAO	Sell	6,805	$113.29	$770,938.45
1/15/2015	Herbert A Fritch	Insider	Sell	35,864	$107.04	$3,838,882.56
12/15/2014	Herbert A Fritch	Insider	Sell	35,929	$101.67	$3,652,901.43
12/8/2014	Isaiah Harris Jr	Chairman	Sell	437	$104.60	$45,710.20
12/1/2014	John M Murabito	EVP	Sell	12,000	$102.76	$1,233,120.00
9/10/2014	Jane E Md Henney	Director	Sell	475	$95.98	$45,590.50
8/18/2014	Jason D Sadler	Insider	Sell	11,000	$93.02	$1,023,220.00
8/1/2014	Isaiah Harris Jr	Chairman	Sell	1,066	$90.22	$96,174.52
6/13/2014	Thomas A Mccarthy	CFO	Sell	7,206	$90.26	$650,413.56
6/12/2014	Nicole S Jones	EVP	Sell	1,882	$91.02	$171,299.64
6/11/2014	John M Murabito	EVP	Sell	17,519	$91.25	$1,598,608.75
6/10/2014	David Cordani	CEO	Sell	133,523	$89.73	$11,981,018.79
6/2/2014	David D Guilmette	Insider	Sell	6,591	$90.19	$594,442.29
5/13/2014	Jason Sadler	Insider	Sell	6,145	$88.50	$543,832.50	20,879
5/12/2014	Matthew Manders	Insider	Sell	9,905	$87.79	$869,559.95	51,736
5/8/2014	Jason Sadler	Insider	Sell	7,810	$85.59	$668,457.90	27,024
5/7/2014	Mary Hoeltzel	CAO	Sell	3,000	$85.00	$255,000.00	1,691
3/14/2014	John Murabito	EVP	Sell	29,843	$76.70	$2,288,958.10	101,810
3/14/2014	Mary Hoeltzel	CAO	Sell	5,333	$77.72	$414,480.76	1,691
9/12/2013	Nicole Jones	EVP	Sell	1,530	$82.35	$125,995.50	5,337
9/6/2013	John M Murabito	EVP	Sell	24,333	$81.07	$1,972,676.31
8/16/2013	Jason Sadler	Insider	Sell	13,261	$77.81	$1,031,838.41	22,189
8/14/2013	Mary Hoeltzel	CAO	Sell	8,664	$78.26	$678,044.64	1,979
8/7/2013	John Murabito	EVP	Sell	78,589	$77.89	$6,121,297.21	143,546
6/13/2013	David Cordani	CEO	Sell	58,705	$68.63	$4,028,924.15
6/12/2013	Matthew G Manders	Insider	Sell	36,868	$68.75	$2,534,675.00
6/12/2013	Nicole S Jones	EVP	Sell	15,306	$70.08	$1,072,644.48
6/5/2013	Isaiah Harris Jr	Chairman	Sell	5,312	$67.40	$358,028.80
3/11/2013	Mary T Hoeltzel	CAO	Sell	5,712	$60.50	$345,576.00
3/6/2013	Eric C Wiseman	Director	Buy	4,200	$59.30	$249,060.00

(Data available from 1/1/2013 forward)

Cigna (NYSE CI) News Headlines

Source:

Date	Headline
	UBS Reaffirms Buy Rating for Cigna (CI) www.americanbankingnews.com - April 20 at 5:52 PM
	Justice Deparment to review Cigna's acquisition of Express Scripts www.bizjournals.com - April 19 at 9:39 AM
	Cigna (CI) to Post FY2018 Earnings of $13.00 Per Share, Leerink Swann Forecasts www.americanbankingnews.com - April 18 at 8:38 AM
	Cigna (CI) to Post Q1 2018 Earnings of $3.45 Per Share, Leerink Swann Forecasts www.americanbankingnews.com - April 17 at 6:12 AM
	Cigna (CI) Stock Rating Upgraded by Zacks Investment Research www.americanbankingnews.com - April 16 at 1:21 PM
	Cigna (CI) Upgraded by ValuEngine to "Buy" www.americanbankingnews.com - April 15 at 10:34 PM
	Cigna (CI) Cut to Buy at BidaskClub www.americanbankingnews.com - April 15 at 12:04 AM
	Yahoo Finance Live: Midday Movers - Apr 12th, 2018 finance.yahoo.com - April 14 at 9:30 AM
	Cigna (CI) Expected to Announce Quarterly Sales of $11.04 Billion www.americanbankingnews.com - April 13 at 4:50 AM
	Express Scripts: Heads (Cigna Buyout) Or Tails (Go Solo), Investors Can Win Either Way seekingalpha.com - April 12 at 4:37 PM
	Cigna (CI) Rating Reiterated by Royal Bank of Canada www.americanbankingnews.com - April 12 at 1:15 PM
	Brokerages Expect Cigna (CI) to Post $3.39 Earnings Per Share www.americanbankingnews.com - April 11 at 3:14 AM
	Cigna Corporation's First Quarter 2018 Earnings Release Details www.businesswire.com - April 5 at 4:31 PM
	Cigna Corporation’s First Quarter 2018 Earnings Release Details finance.yahoo.com - April 5 at 4:31 PM
	America's Favorite TV Doctors of America Are Now On-Call www.businesswire.com - April 5 at 9:14 AM
	Cigna (CI) Given Consensus Recommendation of "Buy" by Analysts www.americanbankingnews.com - April 4 at 1:47 PM
	Zacks Investment Research Lowers Cigna (CI) to Sell www.americanbankingnews.com - April 4 at 11:15 AM
	Buyout Target Express Scripts Has 30%-Plus Upside www.barrons.com - April 3 at 4:39 PM
	Express Scripts: Is There Any Logic Behind The Sell-Off? seekingalpha.com - April 3 at 4:39 PM
	[$$] Buyout Target Express Scripts Has 30%-Plus Upside finance.yahoo.com - April 3 at 4:39 PM
	Walmart Eyes Growth Avenues—Healthcare Could Be One finance.yahoo.com - April 3 at 9:37 AM
	Cigna's CEO told us how his company's $67 billion deal for Express Scripts represents an 'evolution in the marketplace ... www.businessinsider.com - April 2 at 4:36 PM
	Leerink's Takeaways From CNBC's 'Healthy Returns' Conference finance.yahoo.com - March 31 at 4:32 PM
	Trump makes a house call to replace Veterans Affairs Secretary finance.yahoo.com - March 31 at 4:32 PM
	CIGNA (CI) Raised to Buy at ValuEngine www.americanbankingnews.com - March 31 at 3:20 PM
	How local health insurers are battling the opioid crisis www.bizjournals.com - March 30 at 4:37 PM
	The biggest healthcare mergers of the year shouldn't happen — period www.businessinsider.com - March 29 at 9:47 AM
	Cigna Facing More Declines finance.yahoo.com - March 28 at 4:29 PM
	Cigna Says It Reduced Opioid Use By 25% finance.yahoo.com - March 28 at 9:24 AM
	Is Cigna Corporation’s (NYSE:CI) ROE Of 16.19% Sustainable? finance.yahoo.com - March 28 at 9:24 AM
	Cigna's Partnership with Physicians Successfully Reduces Opioid Use by 25 Percent – One Year Ahead of Goal finance.yahoo.com - March 28 at 9:24 AM
	CIGNA Co. (CI) Expected to Post Q1 2018 Earnings of $3.51 Per Share www.americanbankingnews.com - March 28 at 6:34 AM
	$11.01 Billion in Sales Expected for CIGNA Co. (CI) This Quarter www.americanbankingnews.com - March 27 at 8:26 AM
	CIGNA Co. Forecasted to Earn Q4 2018 Earnings of $2.47 Per Share (CI) www.americanbankingnews.com - March 27 at 7:48 AM
	Financial Comparison: CIGNA (CI) and Zurich Insurance Group (ZURVY) www.americanbankingnews.com - March 24 at 7:33 PM
	Healthcare Reform, Top Down And Bottom Up seekingalpha.com - March 24 at 4:57 PM
	/DISREGARD RELEASE: Kahn Swick & Foti, LLC/ finance.yahoo.com - March 21 at 4:48 PM
	The Zacks Analyst Blog Highlights: UnitedHealth, Morgan Stanley, Anheuser-Busch, Cigna and Intuitive Surgical finance.yahoo.com - March 21 at 10:04 AM
	Video: Jim Cramer on What's Next for Cigna and Express Scripts finance.yahoo.com - March 20 at 4:40 PM
	Upside buying in Cigna and this materials stock finance.yahoo.com - March 20 at 4:40 PM
	Zacks Investment Research Downgrades CIGNA (CI) to Hold www.americanbankingnews.com - March 20 at 11:03 AM
	UnitedHealth Group’s Recent Stock Performance finance.yahoo.com - March 19 at 10:11 AM
	CIGNA (CI) Receives New Coverage from Analysts at Sanford C. Bernstein www.americanbankingnews.com - March 18 at 10:24 AM
	Spartanburg Regional Healthcare System's contract with Cigna is ending www.msn.com - March 16 at 4:43 PM
	BRIEF-Cigna Says ‍ Jane Henney, Informed Co, Of Her Intention To Not Seek Re-Election As A Director ‍ www.reuters.com - March 16 at 4:43 PM
	Stocks are selling off today on the huge Retail Sales miss: NYSE trader finance.yahoo.com - March 16 at 4:43 PM
	How to Screen for Classic Value Stocks finance.yahoo.com - March 15 at 10:28 AM
	A.M. Best Places Credit Ratings of Cigna Corporation and Its Insurance Subsidiaries Under Review With Negative Implications finance.yahoo.com - March 13 at 4:50 PM
	Cigna Enters Voice Control Space, Launching “Answers by Cigna” Skill for Amazon Alexa finance.yahoo.com - March 13 at 11:05 AM
	WeissLaw LLP Investigates Express Scripts Holding Co. Acquisition finance.yahoo.com - March 12 at 4:35 PM

Cigna (NYSE:CI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Cigna (NYSE:CI) Income Statement, Balance Sheet and Cash Flow Statement

Cigna (NYSE CI) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff